No abstract available
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antigens, CD / analysis
-
Antigens, Differentiation, Myelomonocytic / analysis
-
Antigens, Neoplasm / analysis
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bevacizumab
-
Biomarkers, Tumor
-
Carboplatin / administration & dosage
-
Carcinoma, Non-Small-Cell Lung / diagnosis
-
Carcinoma, Non-Small-Cell Lung / diagnostic imaging
-
Carcinoma, Non-Small-Cell Lung / drug therapy
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Doxorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Glutamates / administration & dosage
-
Guanine / administration & dosage
-
Guanine / analogs & derivatives
-
Histiocytic Sarcoma / diagnosis*
-
Histiocytic Sarcoma / diagnostic imaging
-
Histiocytic Sarcoma / drug therapy
-
Histiocytic Sarcoma / pathology
-
Histiocytic Sarcoma / radiotherapy
-
Humans
-
Lung Neoplasms / diagnosis
-
Lung Neoplasms / diagnostic imaging
-
Lung Neoplasms / drug therapy
-
Male
-
Neoplasms, Multiple Primary / diagnosis
-
Neoplasms, Multiple Primary / drug therapy
-
Palliative Care
-
Pemetrexed
-
Positron-Emission Tomography*
-
Receptors, Cell Surface / analysis
-
Thyroid Neoplasms / chemistry
-
Thyroid Neoplasms / diagnosis*
-
Thyroid Neoplasms / diagnostic imaging
-
Thyroid Neoplasms / drug therapy
-
Thyroid Neoplasms / pathology
-
Thyroid Neoplasms / radiotherapy
-
Tomography, X-Ray Computed*
Substances
-
Antibodies, Monoclonal, Humanized
-
Antigens, CD
-
Antigens, Differentiation, Myelomonocytic
-
Antigens, Neoplasm
-
Biomarkers, Tumor
-
CD163 antigen
-
CD68 antigen, human
-
Glutamates
-
Receptors, Cell Surface
-
Pemetrexed
-
Bevacizumab
-
Guanine
-
Etoposide
-
Doxorubicin
-
Carboplatin
-
Cisplatin